ArticleAmerican journal of epidemiology2021
Invited Commentary: The Society for Epidemiologic Research-Striving for Equity in Our Own Backyard.
Article in American journal of epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Representation and inclusion among members and affiliates of the Society for Epidemiologic Research: findings from the 2021 diversity and inclusion survey.American journal of epidemiology · 2025Article
- Nobles et al. Respond to Commentaries on Representation by Gender and Affiliation in Key Presentation Formats at the Annual Meeting of the Society for Epidemiologic Research.American journal of epidemiology · 2021Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Using a bibliometric approach, Nobles et al. (Am J Epidemiol. 2021;190(9):1710-1720) conducted a study to explore dimensions of participation at the annual meetings of the Society for Epidemiologic Research (SER). Their findings suggested differences in representation by gender and affiliation in key presentation formats, which raises concerns about possible equity issues within the organization. In this commentary, I discuss the context, limitations, and strengths of the study, as well as reflections on interpretation and implications of the findings. Suggested next steps include: continuing the conversation; evaluating SER processes and making needed adjustments with equity in mind; and conducting ongoing surveillance and further research. Nobles et al. have provided a baseline for monitoring trends, as well as a starting point for future research efforts that should aim to refine methodologic aspects of the current study to obtain a more complete range of information. Although firm conclusions about possible determinants cannot be made at this time, the work of Nobles et al. can be expected to raise awareness of equity issues among SER members and the broader epidemiology community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.